| BCBS Texas Medical Policies | Daily Hemodialysis and Hemodialysis in the Home Setting | 2025-04-01 |
| BCBS Texas Medical Policies | Gait Analysis | 2025-04-01 |
| BCBS Texas Medical Policies | Laser Treatment of Vulvovaginal Atrophy (VVA) | 2025-04-01 |
| BCBS Texas Medical Policies | Magnetoencephalography (MEG) and Magnetic Source | 2025-04-01 |
| BCBS Texas Medical Policies | Transanal Endoscopic Microsurgery | 2025-04-01 |
| Aetna | Margetuximab-cmkb (Margenza) | 2025-04-01 |
| UHC UMR Medical and Drug | Enjaymo® (Sutimlimab-Jome) – Commercial Medical Benefit Drug Policy | 2025-04-01 |
| UHC UMR Medical and Drug | Givlaari® (Givosiran) – Commercial Medical Benefit Drug Policy | 2025-04-01 |
| UHC UMR Medical and Drug | Somatostatin Analogs – Commercial Medical Benefit Drug Policy | 2025-04-01 |
| UHC Surest Medical and Drug | Enjaymo® (Sutimlimab-Jome) – Commercial Medical Benefit Drug Policy | 2025-04-01 |